FDA approves Vyloy for advanced gastric or gastroesophageal junction cancer

by Lori SolomonThe U.S. Food and Drug Administration has approved Vyloy (zolbetuximab-clzb) in combination with fluoropyrimidine- and platinum-containing chemotherapy for the first-line treatment of a

Updated on: November 07,2024

FDA approves Vyloy for advanced gastric or gastroesophageal junction cancer

by Lori SolomonThe U.S. Food and Drug Administration has approved Vyloy (zolbetuximab-clzb) in combination with fluoropyrimidine- and platinum-containing chemotherapy for the first-line treatment of a

Updated on:November 07,2024

Researchers identify possible role of Foxp1 protein in control of autoimmune diseases

by National Research University Higher School of EconomicsCredit: CC0 Public DomainScientists at the Higher School of Economics, the Institute of Bioorganic Chemistry of the Russian Academy of Science

Updated on: June 24,2024

Researchers identify possible role of Foxp1 protein in control of autoimmune diseases

by National Research University Higher School of EconomicsCredit: CC0 Public DomainScientists at the Higher School of Economics, the Institute of Bioorganic Chemistry of the Russian Academy of Science

Updated on:June 24,2024

Researchers create a drug to extend the lives of men with prostate cancer

by Stuart Wolpert,University of California, Los AngelesMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0Fifteen ye

Updated on: June 24,2024

Researchers create a drug to extend the lives of men with prostate cancer

by Stuart Wolpert,University of California, Los AngelesMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0Fifteen ye

Updated on:June 24,2024

Heterogeneity of liver cancer cells helps explain tumor progression in patients

byThe Mount Sinai HospitalCredit: CC0 Public DomainMany liver cancer tumors contain a highly diverse set of cells, a phenomenon known as intra-tumor heterogeneity that can significantly affect t

Updated on: December 20,2023

Heterogeneity of liver cancer cells helps explain tumor progression in patients

byThe Mount Sinai HospitalCredit: CC0 Public DomainMany liver cancer tumors contain a highly diverse set of cells, a phenomenon known as intra-tumor heterogeneity that can significantly affect t

Updated on:December 20,2023

Researchers confirm links between aggressive prostate cancer and hereditary breast cancer

by The Spanish National Cancer Research CentreDavid Olmos and Elena Castro, from the CNIO Prostate Cancer Clinical Research Unit. Credit: CNIOAggressive prostate cancer, one of the leading causes

Updated on: June 01,2024

Researchers confirm links between aggressive prostate cancer and hereditary breast cancer

by The Spanish National Cancer Research CentreDavid Olmos and Elena Castro, from the CNIO Prostate Cancer Clinical Research Unit. Credit: CNIOAggressive prostate cancer, one of the leading causes

Updated on:June 01,2024

Could the zika virus fight the brain cancer that killed john McCain?

by E.j. Mundell, Healthday Reporter(HealthDay)—Preliminary research in mice suggests that the Zika virus might be turned from foe into friend—enlisted to curb deadly glioblastoma brain tumors.A gliobl

Updated on: April 18,2024

Could the zika virus fight the brain cancer that killed john McCain?

by E.j. Mundell, Healthday Reporter(HealthDay)—Preliminary research in mice suggests that the Zika virus might be turned from foe into friend—enlisted to curb deadly glioblastoma brain tumors.A gliobl

Updated on:April 18,2024

Study shows Meteorin-like protein drains energy from T cells, limiting immune system's power to fight cancer

byJohns Hopkins University School of MedicineThe image on the right shows an unhealthy mitochondrion in a T cell exposed to METRNL. Credit: Christopher Jackson, M.D.A protein called Meteorin-lik

Updated on: August 27,2024

Study shows Meteorin-like protein drains energy from T cells, limiting immune system's power to fight cancer

byJohns Hopkins University School of MedicineThe image on the right shows an unhealthy mitochondrion in a T cell exposed to METRNL. Credit: Christopher Jackson, M.D.A protein called Meteorin-lik

Updated on:August 27,2024

Significant proportion of cancer drugs lack proof of added benefit, finds study

by British Medical JournalCredit: CC0 Public DomainMany cancer drugs approved by the European Medicines Agency (EMA) between 1995 and 2020 lack proof of added benefit, particularly those approved

Updated on: May 26,2024

Significant proportion of cancer drugs lack proof of added benefit, finds study

by British Medical JournalCredit: CC0 Public DomainMany cancer drugs approved by the European Medicines Agency (EMA) between 1995 and 2020 lack proof of added benefit, particularly those approved

Updated on:May 26,2024

Addition of durvalumab, bevacizumab to TACE beneficial in liver cancer

by Elana GotkineFor patients with embolization-eligible unresectable hepatocellular carcinoma (uHCC), the addition of durvalumab (D) and bevacizumab (B) to transarterial chemoembolization (TACE) impro

Updated on: March 22,2024

Addition of durvalumab, bevacizumab to TACE beneficial in liver cancer

by Elana GotkineFor patients with embolization-eligible unresectable hepatocellular carcinoma (uHCC), the addition of durvalumab (D) and bevacizumab (B) to transarterial chemoembolization (TACE) impro

Updated on:March 22,2024

Neuro-oncology experts reveal how to use AI to improve brain cancer diagnosis, monitoring and treatment

byIndiana UniversityIU School of Medicine's Spyridon Bakas said the new recommendations are a much-needed update to the current standard of care in which individual radiologists measure tumo

Updated on: December 01,2024

Neuro-oncology experts reveal how to use AI to improve brain cancer diagnosis, monitoring and treatment

byIndiana UniversityIU School of Medicine's Spyridon Bakas said the new recommendations are a much-needed update to the current standard of care in which individual radiologists measure tumo

Updated on:December 01,2024

A peptide-drug conjugate that targets the acidic environment of cancer cells may improve the efficacy of immunotherapy

by American Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainA peptide-drug conjugate that targets the acidic environment of cancer cells enhanced the efficacy of immune checkpoint

Updated on: March 25,2024

A peptide-drug conjugate that targets the acidic environment of cancer cells may improve the efficacy of immunotherapy

by American Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainA peptide-drug conjugate that targets the acidic environment of cancer cells enhanced the efficacy of immune checkpoint

Updated on:March 25,2024

Clinical trial examines standard vs. extended lymph node removal for muscle-invasive bladder cancer

by SWOG Cancer Research NetworkCredit: Pixabay/CC0 Public DomainFinal results from the SWOG S1011 randomized Phase III clinical trial, published in theNew England Journal of Medicine, indicate p

Updated on: November 10,2024

Clinical trial examines standard vs. extended lymph node removal for muscle-invasive bladder cancer

by SWOG Cancer Research NetworkCredit: Pixabay/CC0 Public DomainFinal results from the SWOG S1011 randomized Phase III clinical trial, published in theNew England Journal of Medicine, indicate p

Updated on:November 10,2024